{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:42Z","timestamp":1788307782523,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.imlet.2024.106946","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T17:18:26Z","timestamp":1731863906000},"page":"106946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Vaccine safety in children with genetically confirmed mitochondrial disease"],"prefix":"10.1016","volume":"271","author":[{"given":"Annemarie","family":"de Vreugd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz A.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Steinbr\u00fccker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian CH","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0590-678X","authenticated-orcid":false,"given":"Martina","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia B.","family":"Wortmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2024.106946_bib0001","unstructured":"W. International. 2024. https:\/\/www.who.int\/health-topics\/vaccines-and-immunization."},{"key":"10.1016\/j.imlet.2024.106946_bib0002","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.jaip.2019.03.046","article-title":"Vulnerability of pediatric patients with mitochondrial disease to vaccine-preventable diseases","volume":"7","author":"Kruk","year":"2019","journal-title":"J. Aller. Clin. Immunol. Pract"},{"key":"10.1016\/j.imlet.2024.106946_bib0003","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archotol.128.4.355","article-title":"The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection","volume":"128","author":"Edmonds","year":"2002","journal-title":"Arch. Otolaryngol. Head Neck Surg"},{"key":"10.1016\/j.imlet.2024.106946_bib0004","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10545-012-9492-z","article-title":"Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases","volume":"35","author":"Koene","year":"2012","journal-title":"J. Inherit. Metab. Dis"},{"key":"10.1016\/j.imlet.2024.106946_bib0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pediatrneurol.2005.12.004","article-title":"Acute metabolic crisis induced by vaccination in seven Chinese patients","volume":"35","author":"Yang","year":"2006","journal-title":"Pediatr. Neurol"},{"key":"10.1016\/j.imlet.2024.106946_bib0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaip.2014.02.009","article-title":"Predisposition to infection and SIRS in mitochondrial disorders: 8 years' experience in an academic center","volume":"2","author":"Walker","year":"2014","journal-title":"J. Aller. Clin. Immunol. Pract"},{"key":"10.1016\/j.imlet.2024.106946_bib0007","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pediatrneurol.2016.10.006","article-title":"Cause of death in children with mitochondrial diseases","volume":"66","author":"Eom","year":"2017","journal-title":"Pediatr. Neurol"},{"key":"10.1016\/j.imlet.2024.106946_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ridd.2022.104346","article-title":"Short report: vaccine attitudes in the age of COVID-19 for a population of children with mitochondrial disease","volume":"131","author":"Gordon-Lipkin","year":"2022","journal-title":"Res. Dev. Disabil"},{"key":"10.1016\/j.imlet.2024.106946_bib0009","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41436-021-01194-x","article-title":"Neutropenia and intellectual disability are hallmarks of biallelic and de novo CLPB deficiency","volume":"23","author":"Wortmann","year":"2021","journal-title":"Genet. Med"},{"key":"10.1016\/j.imlet.2024.106946_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10545-010-9210-7","article-title":"The 3-methylglutaconic acidurias: what's new?","volume":"35","author":"Wortmann","year":"2012","journal-title":"J. Inherit. Metab. Dis"},{"key":"10.1016\/j.imlet.2024.106946_bib0011","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13023-022-02495-3","article-title":"The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence","volume":"17","author":"Hanaford","year":"2022","journal-title":"Orphanet. J. Rare Dis"},{"key":"10.1016\/j.imlet.2024.106946_bib0012","unstructured":"A.s. ministry. Technical information about the vaccines in the public vaccination programs. 2024."},{"key":"10.1016\/j.imlet.2024.106946_bib0013","doi-asserted-by":"crossref","unstructured":"K. Weisser, I. Barth, B. Keller-Stanislawski, [Vaccine safety], Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 52 (2009) 1053\u201364. doi: 10.1007\/s00103-009-0961-y.","DOI":"10.1007\/s00103-009-0961-y"},{"key":"10.1016\/j.imlet.2024.106946_bib0014","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2165\/00044011-200424080-00004","article-title":"Incidence of adverse reactions to vaccines in a paediatric population","volume":"24","author":"Carrasco-Garrido","year":"2004","journal-title":"Clin. Drug Investig"},{"key":"10.1016\/j.imlet.2024.106946_bib0015","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.vaccine.2022.11.033","article-title":"Really just a little prick? A meta-analysis on adverse events in placebo control groups of seasonal influenza vaccination RCTs","volume":"41","author":"Bender","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2024.106946_bib0016","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3707","article-title":"N. Canadian immunization research, risk of recurrence of adverse events following immunization: a systematic review","volume":"140","author":"Zafack","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.imlet.2024.106946_bib0017","doi-asserted-by":"crossref","first-page":"e1147","DOI":"10.1542\/peds.2010-1628","article-title":"Vaccines are not associated with metabolic events in children with urea cycle disorders","volume":"127","author":"Morgan","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.imlet.2024.106946_bib0018","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1016\/j.vaccine.2014.09.003","article-title":"Vaccination recommendations for patients with neuromuscular disease","volume":"32","author":"Esposito","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2024.106946_bib0019","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.imlet.2024.106946_bib0020","first-page":"682","article-title":"Measurement in neurological rehabilitation","volume":"5","author":"Wade","year":"1992","journal-title":"Curr. Opin. Neurol. Neurosurg"},{"key":"10.1016\/j.imlet.2024.106946_bib0021","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.nmd.2006.08.006","article-title":"A scale to monitor progression and treatment of mitochondrial disease in children","volume":"16","author":"Phoenix","year":"2006","journal-title":"Neuromuscul. Disord"},{"key":"10.1016\/j.imlet.2024.106946_bib0022","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10545-014-9773-9","article-title":"High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders","volume":"38","author":"Franik","year":"2015","journal-title":"J. Inherit. Metab. Dis"},{"key":"10.1016\/j.imlet.2024.106946_bib0023","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1016\/j.vaccine.2015.10.073","article-title":"Vaccination coverage of patients with inborn errors of metabolism and the attitudes of their parents towards vaccines","volume":"33","author":"Cerutti","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2024.106946_bib0024","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yapd.2022.03.011","article-title":"Vaccine hesitancy in pediatrics","volume":"69","author":"Lafnitzegger","year":"2022","journal-title":"Adv. Pediatr"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247824001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T21:03:58Z","timestamp":1733691838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247824001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":24,"alternative-id":["S0165247824001202"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106946","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine safety in children with genetically confirmed mitochondrial disease","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2024.106946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"106946"}}